BENEVICH ERIC sold NBIX
September 9, 2026 · Form 4 insider transaction
BENEVICH ERIC sold 2,154 shares of Neurocrine Biosciences, Inc. at $154.61 per share, a transaction worth $333.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,154
Price
$154.61
Total value
$333.0K
InsiderBENEVICH ERIC
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 9, 2026
Filing dateSeptember 10, 2026
Shares owned after64,408
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2026. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.